City

Brussels (1)

Cairo (1)

Condition

Immunoglobulins (3)

Convalescent Plasma (1)

Covid19 (1)

Egypt (1)

Maternal-Fetal Relations (1)

Pertussis (1)

Plasma (1)

Vaccination; Infection (1)

Overall Status

Not yet recruiting (2)

Completed (1)

Sign in for free

Phase

phase 3 (1)

phase 4 (1)

Sponsor

Assistance Publique - Hopitaux de Paris (1)

Centre Hospitalier Universitaire Saint Pierre (1)

Ministry of Health and Population, Egypt (1)

Collaborator

Universite Libre de Bruxelles (1)

Intervention

boostrix® (pertussis-containing vaccine) (1)

convalescent plasma (1)

hexyon® (pertussis-containing vaccine) (1)

nhig prescription (1)

Study Documents

Intervention Type

biological (2)

other (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

immunoglobulins

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Normal Human ImmunoGlobulins: Feasibility of Integrating

Not yet recruiting

Immunoglobulins

NHIg prescription

(no location specified)

Aug 30, 2023

Vaccination; Infection, Maternal-Fetal Relations, Pertussis Trial in Brussels (Boostrix® (Pertussis-containing vaccine), Hexyon®

Not yet recruiting

Vaccination; Infection
+3 more

Boostrix® (Pertussis-containing vaccine)
Hexyon® (Pertussis-containing vaccine)

Brussels, Belgium

CHU Saint-Pierre

May 3, 2023

Convalescent Plasma, Covid19, Immunoglobulins Trial in Cairo (Convalescent Plasma)

Completed

Convalescent Plasma
+4 more

Convalescent Plasma

Cairo, Giza, Egypt

Ministry of Health

Mar 24, 2021